Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling.
Emergency myelopoiesis contributes to immune cell exhaustion and pulmonary vascular remodelling.
复制标题
DOI:
10.1111/bph.14945
复制
发表时间:
2021-01
影响因子:
7.3
通讯作者:
Bryant AJ
中科院分区:
文献类型:
--
作者:
Fu C;Lu Y;Williams MA;Brantly ML;Ventetuolo CE;Morel LM;Mehrad B;Scott EW;Bryant AJ
Pulmonary hypertension (PH) secondary to chronic lung disease (World Health Organization Group 3 PH) is deadly, with lung transplant being the only available long‐term treatment option. Myeloid‐derived cells are known to affect progression of both pulmonary fibrosis and PH, although the mechanism of action is unknown. Therefore, we investigated the effect of myeloid cell proliferation induced by emergency myelopoiesis on development of PH and therapy directed against programmed death‐ligand 1 (PD‐L1), expressed by myeloid cells in prevention of pulmonary vascular remodelling. LysM.Cre‐DTR (“mDTR”) mice were injected with bleomycin (0.018 U·g−1, i.p.) while receiving either vehicle or diphtheria toxin (DT; 100 ng, i.p.) to induce severe PH. Approximately 4 weeks after initiation of bleomycin protocol, right ventricular pressure measurements were performed and tissue samples collected for histologic assessment. In a separate experiment, DT‐treated mice were given anti‐PD‐L1 antibody (αPD‐L1; 500 μg, i.p.) preventive treatment before bleomycin administration. Mice undergoing induction of emergency myelopoiesis displayed more severe PH, right ventricular remodelling and pulmonary vascular muscularization compared to controls, without a change in lung fibrosis. This worsening of PH was associated with increased pulmonary myeloid‐derived suppressor cell (MDSC), particularly polymorphonuclear MDSC (PMN‐MDSC). Treatment with αPD‐L1 normalized pulmonary pressures. PD‐L1 expression was likewise found to be elevated on circulating PMN‐MDSC from patients with interstitial lung disease and PH. PD‐L1 is a viable therapeutic target in PH, acting through a signalling axis involving MDSC. This article is part of a themed issue on Risk factors, comorbidities, and comedications in cardioprotection. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.1/issuetoc
登录
查看更多内容
影响因子:
10.1
作者:
Gabrilovich DI
通讯作者:
Gabrilovich DI
DOI:
10.1183/13993003.00467-2018
发表时间:
2018-06
期刊:
The European respiratory journal
影响因子:
--
作者:
Baird GL;Archer-Chicko C;Barr RG;Bluemke DA;Foderaro AE;Fritz JS;Hill NS;Kawut SM;Klinger JR;Lima JAC;Mullin CJ;Ouyang P;Palevsky HI;Palmisicano AJ;Pinder D;Preston IR;Roberts KE;Smith KA;Walsh T;Whittenhall M;Ventetuolo CE
通讯作者:
Ventetuolo CE
影响因子:
17.1
作者:
Highfill SL;Cui Y;Giles AJ;Smith JP;Zhang H;Morse E;Kaplan RN;Mackall CL
通讯作者:
Mackall CL
DOI:
10.1007/978-1-4939-7837-3_22
发表时间:
2018
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
Hua L;Shi J;Shultz LD;Ren G
通讯作者:
Ren G
影响因子:
16.6
作者:
Bronte V;Brandau S;Chen SH;Colombo MP;Frey AB;Greten TF;Mandruzzato S;Murray PJ;Ochoa A;Ostrand-Rosenberg S;Rodriguez PC;Sica A;Umansky V;Vonderheide RH;Gabrilovich DI
通讯作者:
Gabrilovich DI